Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

[1]  R. Coates,et al.  The epidemiology of triple-negative breast cancer, including race , 2009, Cancer Causes & Control.

[2]  I. Ellis,et al.  Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes , 2009, Clinical Cancer Research.

[3]  L. Brinton,et al.  Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years , 2009, Cancer Epidemiology Biomarkers & Prevention.

[4]  John M L Ebos,et al.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. , 2009, Cancer cell.

[5]  Masahiro Inoue,et al.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.

[6]  T. Uematsu,et al.  Triple-negative breast cancer: correlation between MR imaging and pathologic findings. , 2009, Radiology.

[7]  Daniel Birnbaum,et al.  How basal are triple‐negative breast cancers? , 2008, International journal of cancer.

[8]  I. Ellis,et al.  Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy , 2008, Pathobiology.

[9]  Ian O Ellis,et al.  Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  I. Ellis,et al.  The influence of basal phenotype on the metastatic pattern of breast cancer. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  I. Ellis,et al.  Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications , 2008, Breast Cancer Research and Treatment.

[12]  Robin L. Jones,et al.  Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients , 2008, Breast Cancer Research and Treatment.

[13]  I. Ellis,et al.  Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up , 2007, Journal of medical screening.

[14]  I. Ellis,et al.  Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences , 2007, The American journal of surgical pathology.

[15]  E. Paish,et al.  Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression , 2007, Histopathology.

[16]  S. Krishnamurthy.  Morphological and Immunophenotypic Analysis of Breast Carcinomas With Basal and Myoepithelial Differentiation , 2007 .

[17]  D. Easton,et al.  Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival , 2007, Breast Cancer Research.

[18]  Douglas Macmillan,et al.  Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. , 2006, European journal of cancer.

[19]  H. Augustin,et al.  The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. , 2006, The American journal of pathology.

[20]  J. Benítez,et al.  Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas , 2006, Clinical Cancer Research.

[21]  R W Blamey,et al.  Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.

[22]  T. Trikalinos,et al.  Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach , 2005, Modern Pathology.

[23]  A. Harris,et al.  A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity , 2005, British Journal of Cancer.

[24]  S. Natsugoe,et al.  Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer , 2005, British Journal of Cancer.

[25]  Qiqin Yin-Goen,et al.  Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression , 2005, Modern Pathology.

[26]  Misa Nakamura,et al.  Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer , 2005, Breast Cancer Research and Treatment.

[27]  P. Heikkilä,et al.  High LYVE-1–Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer , 2004, Clinical Cancer Research.

[28]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[29]  W Vach,et al.  Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients , 2004, Histopathology.

[30]  Patrick Nicolas,et al.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.

[31]  N. Weidner,et al.  Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study , 2004, Breast Cancer Research and Treatment.

[32]  S. Tsutsui,et al.  Prognostic value of microvessel density in invasive ductal carcinoma of the breast , 2003, Breast cancer.

[33]  R. Gelber,et al.  Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Skobe,et al.  Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Breiteneder-Geleff,et al.  Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. , 2001, Anticancer research.

[37]  M. Schindl,et al.  Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[39]  O. Nanni,et al.  Tumor microvessel density and prognosis in node‐negative breast cancer , 2000, International journal of cancer.

[40]  I. Bleiweiss,et al.  Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. , 1999, Annals of surgery.

[41]  S. Holck,et al.  Quantification of microvessel density of breast carcinoma: an assessment of the inter- and intraobserver variation. , 1999, Breast.

[42]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[43]  H. Yeger,et al.  Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours , 1999, British Journal of Cancer.

[44]  H. Kowalski,et al.  [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma]. , 1999, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[45]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[46]  D. Carney,et al.  Prognostic significance of microvessel density in lymph node negative breast carcinoma. , 1995, Human pathology.

[47]  C Kurz,et al.  Microvessel density and vessel invasion in lymph‐node‐negative breast cancer: Effect on recurrence‐free survival , 1995, International journal of cancer.

[48]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.

[49]  M. Toi,et al.  Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma , 1993, International journal of cancer.

[50]  J. Zehnder,et al.  The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. , 1992, The Journal of biological chemistry.

[51]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.